Mycophenolate mofetil Recruiting Phase 2 Trials for Marginal Zone B-Cell Lymphoma / Mantle Cell Lymphoma (MCL) / Lymphoplasmacytic Lymphoma / Leukemia, Prolymphocytic / Myelodysplastic Syndrome / Leukemia, Plasma Cell / MRD Positive Leukemia / Leukemia or MDS in Aplasia / Lymphoma, Hodgkins / relapsed Small Lymphocytic Lymphoma / Myeloproliferative Syndromes / Leukemia Acute Myeloid Leukemia (AML) / Follicular Lymphoma (FL) / Leukemia, Acute / Chronic Lymphocytic Leukaemia (CLL) / recurrent Cutaneous T-cell lymphoma / Acute Lymphoblastic Leukemia/Lymphoma / Bone Marrow Failure Syndromes / Burkitt's Lymphoma / Relapsed Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (SLL) / Multiple Myeloma (MM) / Lymphoma, Large-Cell / chronic Chronic myelogenous leukemia / Natural Killer Cell Malignancies / Biphenotypic/Undifferentiated/Prolymphocytic Leukemias / Myeloproliferative Neoplasms/Myelofibrosis / Relapsed Multiple Myeloma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02722668UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
NCT02782546Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation